Study looked at 332 preferred share financing transactions worth US$5.7 billion between 2019-2021
A recent Osler Hoskin & Harcourt LLP report on venture capital financings in Canada between 2019 and 2021 shows that COVID-19 did create a short bump in the road on some dealmaking. Still, series seed, series A, and later-stage financings sustained remarkable growth during a tumultuous period.
The Deal Points report is based on 332 preferred share financing transactions completed by Osler, either as company counsel or issuer counsel in those three years, with a total aggregate transaction value of just under US$5.7 billion. These ranged from series seed financings through to series D financings.
Of the financing transactions included in the Deal Points report, Osler was company counsel in 71.9 percent of these financing transactions and investor counsel in 28.1 percent of these financings. Approximately 8 percent of transactions involved a U.S. company in instances where a Canadian office of Osler was engaged in the transaction.
“It’s a unique report,” said Michael Grantmyre, partner with Osler’s emerging and high-growth companies practice, during a webinar presentation Tuesday. In the presentation, he and co-authors Mark Longo and Chad Bayne outlined the report’s details.
In terms of the data being used, Grantmyre said the study went “beyond public sources of information which sometimes only scratched the surface of what is really important to people in the space,” he said, stressing that they went to “great pains” to anonymize the data.
However, “those sources of information include things like term sheets, subscription agreements, [and] shareholder deal documents relating to secondary sale transactions,” he added. “And what makes the report special from our perspective, and why we’re so excited about it, is that it’s really an opportunity to celebrate the vibrant [venture capital] ecosystem that we have here in Canada.”
Bayne noted that completing financing rounds of $100 million or more, regularly, was almost unheard of in the past, “but a financing of $50 million or more today is now the norm.” He added that it is “definitely a coming-of-age story” for Canadian companies.
Longo agreed, saying, “there was so much dry powder out there in terms of Canadian growth, equity funds, U.S. and international growth equity funds, there’s no question Canada is now on the radar.”
Highlights of the report include:
On valuations, Grantmyre said that while they have been “frothy,” throughout 2021, they have more recently slipped. Bayne noted that towards the end of 2021, “the world started changing again, and we’re now into this new period of high inflation and talk of interest rate increases, and a really unfortunate war in Eastern Europe.”
The result is that people are more nervous, and valuation pressure downwards. “We’ve had a pretty good bull run for the last couple of years, and now I think everybody’s just taking a pause to see what ultimately happens,” Bayne said. The thought is “we’re headed into some stronger headwinds than we’ve seen in many years.”
In concluding the webinar, Longo said heading into 2022 and beyond, there will still be a “tremendous amount” of deal activity, “given the trillion dollar-plus dry powder that is out there in growth, equity and venture capital funds.”
At the same time, he noted there will likely be a “recalibration” of valuations, likely to the downside, and there will be a gap between the company and the investor’s views on fair valuation that will need to come closer together “to get deals done.”
Still, “we think there’s going to be a lot of [transactional] activity out there.”